Subtype specific targeting of calcium signaling in breast cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

1. Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial.Scientific reports · 2023
   Trial
2. Exploring the pharmacological action mechanism of chamomile essential oil on the treatment of breast cancer based on network pharmacology.BMC complementary medicine and therapies · 2025
   Article
3. Store-operated calcium entry-based targets for novel cancer therapeutic development.The Journal of pharmacology and experimental therapeutics · 2025
   Review
4. iScience · 2025
   Article
5. Review of electrophysiological models to study membrane potential changes in breast cancer cell transformation and tumor progression.Frontiers in physiology · 2025
   Review
6. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.Cancers · 2024
   Review
7. Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance.Cancers · 2024
   Article
8. Identifying Lymph Node Metastasis-Related Factors in Breast Cancer Using Differential Modular and Mutational Structural Analysis.Interdisciplinary sciences, computational life sciences · 2023
   Article
9. Structure and transport mechanism of the human calcium pump SPCA1.Cell research · 2023
   Article
10. The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer.Biomedicines · 2023
    Review
11. The role of extended synaptotagmin at membrane contact sites in cancer research.Frontiers in cell and developmental biology · 2023
    Review
12. Identification of Three Circulating MicroRNAs in Plasma as Clinical Biomarkers for Breast Cancer Detection.Journal of clinical medicine · 2022
    Article
13. Pathophysiological role of ion channels and transporters in HER2-positive breast cancer.Cancer gene therapy · 2022
    Review
14. Molecular perspective on targeted therapy in breast cancer: a review of current status.Medical oncology (Northwood, London, England) · 2022
    Review
15. Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer.Cancer drug resistance (Alhambra, Calif.) · 2022
    Review
16. Role of Calcium Homeostasis in Modulating EMT in Cancer.Biomedicines · 2021
    Review
17. Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells.Cancers · 2021
    Article
18. Biological Regulatory Network (BRN) Analysis and Molecular Docking Simulations to Probe the Modulation of IPGenes · 2020
    Article
19. Calcium signaling: breast cancer's approach to manipulation of cellular circuitry.Biophysical reviews · 2020
    Review
20. Calcium Metabolism and Breast Cancer: Echoes of Lactation?Current opinion in endocrine and metabolic research · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as